Tekla Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 210,789 shares of BMRN stock, worth $14.6 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

210,789

Previous 300,089 29.76%

Holding current value

$14.6 Million

Previous $29.2 Million 37.39%

% of portfolio

0.72%

Previous 1.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $7.74 Million - $8.96 Million	-89,300 Reduced 29.76%	210,789 $18.3 Million
Q1 2023 May 10, 2023	BUY	$87.74 - $117.27 $6.08 Million - $8.13 Million	69,299 Added 30.03%	300,089 $29.2 Million
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $6.46 Million - $8.67 Million	79,843 Added 52.89%	230,790 $23.9 Million
Q3 2022 Nov 01, 2022	BUY	$82.16 - $96.94 $1.88 Million - $2.22 Million	22,943 Added 17.92%	150,947 $12.8 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $11.2 Million - $13.6 Million	-150,326 Reduced 54.01%	128,004 $9.67 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $3.45 Million - $4.28 Million	-47,492 Reduced 14.58%	278,330 $24.4 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $5.78 Million - $10.5 Million	80,460 Added 32.79%	325,822 $24.8 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $2.01 Million - $3.14 Million	-25,251 Reduced 9.33%	245,362 $30.3 Million
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $424,437 - $575,966	-5,947 Reduced 2.15%	270,613 $22.9 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $1.98 Million - $2.66 Million	30,797 Added 12.53%	276,560 $23.4 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.9 Million - $2.22 Million	23,677 Added 10.66%	245,763 $21.1 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $1.23 Million - $1.44 Million	14,652 Added 7.06%	222,086 $19.7 Million
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $5.36 Million - $7.1 Million	66,896 Added 47.6%	207,434 $17.7 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $10.7 Million - $13.9 Million	-140,538 Reduced 50.0%	140,538 $13.2 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $16.2 Million - $19.3 Million	-208,669 Reduced 42.61%	281,076 $22.8 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $969,120 - $1.14 Million	-12,000 Reduced 2.39%	489,745 $43.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	501,745	501,745 $45.6 Million

Others Institutions Holding BMRN

# of Institutions

628

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Biomarin Pharmaceutical Inc Transaction History